摘要:
The invention relates to a method for production of azo compounds. In particular the invention relates to a step-wise method for production of an azo compound, by seeding and oxidation of the corresponding hydrazoic compound.
摘要:
The present invention refers to a procedure for preparing azo compounds comprising a reaction between at least: one amine or polyamine, molecular oxygen, a catalyst comprising at least one support selected from at least a metal oxide of one of the elements of the groups 3, 4, 5, 6, 8, 9, 11 and 13, silica, an anionic laminar compound of hydrotalcite type or its derivatives, active carbon or an organic polymer. In addition, said catalyst may contain nanoparticles of gold.
摘要:
The invention relates to a method for production of azo compounds. In particular the invention relates to a step-wise method for production of an azo compound, by seeding and oxidation of the corresponding hydrazoic compound.
摘要:
Compounds of formula (I) and pharmaceutically acceptable salts thereof: wherein a and b together form an -O- or -CH₂- linkage or a bond; either Y is N and R₂ is hydrogen; or Y is C-R₁ wherein either one of R₁ and R₂ is hydrogen and the other is nitro, cyano, halo, CF₃, formyl, aldoxime, CF₃O, NO₂-CH=CH-, NC-CH=CH-; a group R x X- wherein R x is C₁₋₆ alkyl, aryl or heteroaryl either of which may be optionally substituted by one, two or three of C₁₋₄ alkyl, C₁₋₄ alkoxy, nitro, halo, CF₃ and cyano; and X is C=O, O.C=O, C=O.O, CHOH, SO, SO₂, O.SO, O.SO₂, CONH, O.CONH, C=S, O.C=S, C=S.O, CH.SH, SONH, SO₂NH, O.SONH, O.SO₂NH, CO-CH=CH, C=NHOH, C=NNH₂; or a group R y R z NZ- wherein R y and R z are independently hydrogen or C₁₋₆ alkyl and Z is C=O, SO or SO₂; or R₁ is a C₃₋₈ cycloalkyl group or a C₁₋₆ alkyl group optionally substituted by a group which is hydroxy, C₁₋₆ alkoxy, amino optionally substituted by one or two C₁₋₆ alkyl groups, C₁₋₇ alkanoylamino, C₃₋₈ cycloalkyloxy or C₃₋₈ cycloalkylamino; and R₂ is hydrogen; or one of R₁ and R₂ is nitro, cyano or C₁₋₃ alkylcarbonyl and the other is a different group selected from nitro, cyano, halo, C₁₋₃ alkylcarbonyl, methoxy or amino optionally substituted by one or two C₁₋₆ alkyl or by C₂₋₇ alkanoyl; either one of R₃ and R₄ is hydrogen or C₁₋₄ alkyl and the other is C₁₋₄ alkyl; or R₃ and R₄ together are C₂₋₅ polymethylene; either R₅ is hydrogen, hydroxy, C₁₋₆ alkoxy or C₁₋₇ acyloxy; and R₆ is hydrogen; or R₅ and R₆ together are a bond; either R₇ is hydrogen, C₁₋₆ alkyl, C₃₋₆ cycloalkyl, C₂₋₆ alkenyl or C₂₋₆ alkynyl; and R₈ is hydrogen or C₁₋₆ alkyl; or R₇ and R₈ together are C₂₋₄ polymethylene; R₉ is CN, NO₂, COR₁₀ or SO₂R₁₀ wherein R₁₀ is C₁₋₃ alkyl, NH₂, NH(C₁₋₃ alkyl), CF₃ or phenyl optionally substituted as defined for R x ; and the R₈N(NR₉)NHR₇ moiety is trans to the R₅ group when R₅ is hydroxy, C₁₋₆ alkoxy or C₁₋₇ acyloxy; having antihypertensive and/or bronchodilator activity, processes for their preparation and their use as pharmaceuticals.